John Barrett, MD
Radiation Oncology · Augusta, GANPI 1568571537
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Novocure Inc. at 47.2% of the total. Reporting peaked in 2023 at $286 and has fallen 63.0% since, to $106 in 2025.
Across 17 payments — averaging $58.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$471
- Elekta, Inc.$191
- AbbVie$102
- Siemens Medical Solutions USA, Inc.$69
- Reflexion Medical, Inc.$62
- Visionrt, Inc.$30
- plus $73 from 4 others
What the payments were for
- Food & beverage$999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 4 | $471 |
| Elekta, Inc. | 2 | $191 |
| AbbVie | 1 | $102 |
| Siemens Medical Solutions USA, Inc. | 3 | $69 |
| Reflexion Medical, Inc. | 2 | $62 |
| Visionrt, Inc. | 1 | $30 |
| Boston Scientific | 1 | $24 |
| Varian Medical Systems, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
| Isoray, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune$471
- LEKSELL GAMMA KNIFE ICON$106
- DALVANCE$102
How this compares
$999 in reported general payments places this provider in the 65th percentile of 165 radiation oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 14 | $39,057 |
| Tamsulosin Hcl | 17 | $190 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Augusta
- John StewartAugusta$2K
- Jed HowingtonAugusta$1K
- Rohit RajAugusta$931
- Kristin HigginsAtlanta$230K
- Walter CurranAtlanta$83K
- Ian CrockerAtlanta$51K
- Sagar PatelAtlanta$32K
- Hui-Kuo ShuAtlanta$25K
- Wilfred WilliamsAtlanta$15K
- Nancy WiggersAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.